Here we report the results of an in vivo study in three RAS WT human colon cancer xenografts as relevant models for EGFR inhibitor-sensitive mCRC to better define the anti-tumor activity of MM151 as compared to cetuximab. This evidence concerns the gene EGFR and neoplasm.